22 related articles for article (PubMed ID: 15932749)
1. The Anti-Parkinsonism Effects of K
Piri H; Haghdoost-Yazdi H; Fraidouni N; Dargahi T; Yaghoubidoust M; Azadmehr A
Basic Clin Neurosci; 2017; 8(3):183-192. PubMed ID: 28781726
[TBL] [Abstract][Full Text] [Related]
2. Role of transcription factor yin yang 1 in manganese-induced reduction of astrocytic glutamate transporters: Putative mechanism for manganese-induced neurotoxicity.
Karki P; Smith K; Johnson J; Aschner M; Lee E
Neurochem Int; 2015 Sep; 88():53-9. PubMed ID: 25128239
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of glutamate dehydrogenase block sodium-dependent glutamate uptake in rat brain membranes.
Whitelaw BS; Robinson MB
Front Endocrinol (Lausanne); 2013; 4():123. PubMed ID: 24062726
[TBL] [Abstract][Full Text] [Related]
4. Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation.
Carbone M; Duty S; Rattray M
BMC Neurosci; 2012 Apr; 13():38. PubMed ID: 22480308
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional profiles for glutamate transporters reveal differences between organophosphates but similarities with unrelated neurotoxicants.
Slotkin TA; Lobner D; Seidler FJ
Brain Res Bull; 2010 Aug; 83(1-2):76-83. PubMed ID: 20600679
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic promise and principles: metabotropic glutamate receptors.
Maiese K; Chong ZZ; Shang YC; Hou J
Oxid Med Cell Longev; 2008; 1(1):1-14. PubMed ID: 19750024
[TBL] [Abstract][Full Text] [Related]
7. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.
Sheldon AL; Robinson MB
Neurochem Int; 2007; 51(6-7):333-55. PubMed ID: 17517448
[TBL] [Abstract][Full Text] [Related]
8. Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.
Maiese K; Chong ZZ; Li F
Curr Neurovasc Res; 2005 Dec; 2(5):425-46. PubMed ID: 16375723
[TBL] [Abstract][Full Text] [Related]
9. Effects of systemic administration of iptakalim on extracellular neurotransmitter levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats.
Wang S; Hu LF; Zhang Y; Sun T; Sun YH; Liu SY; Ding JH; Wu J; Hu G
Neuropsychopharmacology; 2006 May; 31(5):933-40. PubMed ID: 16123757
[TBL] [Abstract][Full Text] [Related]
10. Iptakalim hydrochloride protects cells against neurotoxin-induced glutamate transporter dysfunction in in vitro and in vivo models.
Yang YL; Meng CH; Ding JH; He HR; Ellsworth K; Wu J; Hu G
Brain Res; 2005 Jul; 1049(1):80-8. PubMed ID: 15932749
[TBL] [Abstract][Full Text] [Related]
11. Iptakalim protects PC12 cell against H2O2-induced oxidative injury via opening mitochondrial ATP-sensitive potassium channel.
Chai Y; Niu L; Sun XL; Ding JH; Hu G
Biochem Biophys Res Commun; 2006 Nov; 350(2):307-14. PubMed ID: 17010314
[TBL] [Abstract][Full Text] [Related]
12. [Iptakalim enhances astrocytic glutamate uptake activity].
Zhang Y; Hu G
Yao Xue Xue Bao; 2004 Dec; 39(12):980-3. PubMed ID: 15813025
[TBL] [Abstract][Full Text] [Related]
13. ATP-sensitive potassium channel opener iptakalim protected against the cytotoxicity of MPP+ on SH-SY5Y cells by decreasing extracellular glutamate level.
Hu LF; Wang S; Shi XR; Yao HH; Sun YH; Ding JH; Liu SY; Hu G
J Neurochem; 2005 Sep; 94(6):1570-9. PubMed ID: 16000145
[TBL] [Abstract][Full Text] [Related]
14. Iptakalim ameliorates MPP+-induced astrocyte mitochondrial dysfunction by increasing mitochondrial complex activity besides opening mitoK(ATP) channels.
Zhang S; Ding JH; Zhou F; Wang ZY; Zhou XQ; Hu G
J Neurosci Res; 2009 Apr; 87(5):1230-9. PubMed ID: 19006086
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
